Clinical Trials Logo

Filter by:
NCT ID: NCT04834596 Not yet recruiting - Clinical trials for Detection of Liver Metastases

Detection and Automatic Segmentation of Liver Nodules in Patients With Colorectal Adenocarcinoma

OOPS
Start date: May 2, 2021
Phase:
Study type: Observational

Evaluation of the diagnostic performance of artificial intelligence-based software for the detection of liver nodules on scanner in patients at risk of liver metastases of colorectal cancer

NCT ID: NCT04833933 Completed - Smoking Cessation Clinical Trials

Impact of Primary Care COPD Screening Strategies on the Smoking Cessation Process (DISCO-SET)

DISCO-SET
Start date: April 7, 2021
Phase:
Study type: Observational

The general practitioner is confronted with unselected smokers whose attempts to quit smoking are often repeated over time before leading to a definitive cessation. Each year, 3-5% of smokers succeed in quitting in the general population. The corollary is that the majority of smokers are in a situation of failure in their attempt to quit: 33% declared during the 2019 French Health Barometer to have made an attempt of at least 7 days in the past year. Thus, this status of "smoker" can cover a wide variety of situations: no attempt to stop smoking, attempt(s) of more or less clinical significance, previous support or not by a health professional, etc. Currently, the HAS recommendations do not determine a specific course of action for these smokers, whose experiences may be very different. It could therefore be interesting to objectivize the smoking cessation process of these patients who have or have not succeeded in quitting, in order to deduce profiles of smokers according to their previous smoking cessation experiences. Furthermore, the choice and relevance of the cessation criteria used are debated. Following the randomized controlled trial DISCO on COPD screening interventions in primary care (3 intervention arms, 1 control arm), the investigators will carry out a pilot cross-sectional survey on the cessation process of smokers during the 2 years following their participation, evaluating the incidence and modalities of cessation attempts of smokers belonging to an age group at risk of COPD (40-80 years) and who initially consulted their general practitioner for any reason 2 years ago at the time of their inclusion. The impact on future management could be the personalization of cessation advice given to smokers according to quantitative and qualitative indicators specific to their experience, their previous history of smoking cessation, their health situation and socio-demographic characteristics. Eventually, a gradation of the levels of support offered to patients in general practice on the basis of predictive factors of smoking cessation could be studied. The investigators hypothesize that participation in COPD screening with the GP may be associated with patient progress in quitting smoking. This pilot study will be conducted on a random sample of 120 participants from the subgroup of 544 patients who were smokers at inclusion in DISCO.

NCT ID: NCT04833894 Recruiting - Clinical trials for Generalized Myasthenia Gravis

Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis

Start date: October 26, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this trial is to investigate the PK, PD, safety, and activity of efgartigimod IV in children and adolescents aged from 2 to less than 18 years of age with gMG. Trial details include: - The maximum trial duration for each individual participant will be approximately 28 weeks - The treatment duration will be 8 weeks for the dose-confirmatory part (Part A) and 18 weeks for the treatment response-confirmatory part (Part B)

NCT ID: NCT04833855 Completed - Clinical trials for Chronic Spontaneous Urticaria

Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria

INCEPTION
Start date: April 15, 2021
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to evaluate the effect of tezepelumab on improvement in the Urticaria Activity Score over 7 days (UAS7).

NCT ID: NCT04833816 Recruiting - Traumatic Injury Clinical Trials

Ketamine Low dOse Evaluation on Morphine Consumption in Traumatic Patient

KLOE
Start date: August 5, 2022
Phase: Phase 3
Study type: Interventional

The aim of this study is to demonstrate a significant reduction of at least 25% in opioid consumption at 48 hours of management of severe trauma, while demonstrating non-inferiority in terms of analgesia, in a group of patients receiving a continuous infusion of low dose ketamine compared to a placebo group.

NCT ID: NCT04833582 Active, not recruiting - Osteosarcoma Clinical Trials

A Study of ZN-c3 in Combination With Gemcitabine in Subjects With Osteosarcoma

Start date: August 1, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This is a phase 1/2 study of ZN-c3 in combination with gemcitabine in adult and pediatric subjects with relapsed or refractory osteosarcoma.

NCT ID: NCT04833348 Recruiting - Clinical trials for Spinal Muscular Atrophy

Quantification of Motor Function in Infants With Spinal Muscular Atrophy Treated With Innovative Therapies

IMUSMA
Start date: March 20, 2021
Phase: N/A
Study type: Interventional

The aim of the study is to propose a method for quantifying motor function in infants with spinal muscular atrophy treated with innovative therapies using inertial sensors.

NCT ID: NCT04833335 Recruiting - Brain Metastases Clinical Trials

ASL in Brain Metastasis MRI Following Gamma Knife Treatment

GK-ASL
Start date: January 24, 2023
Phase: N/A
Study type: Interventional

Arterial spin labeling (ASL) is a non-invasive MRI technique that could help the radiologists to distinguish brain metastasis progression versus radionecrosis following gamma-knife treatment. The primary target of the study is to establish the diagnostic performances (specificity, sensitivity) of quantitative measures of ASL in brain metastases suspected of progression/radionecrosis after GK treatment

NCT ID: NCT04832646 Recruiting - Clinical trials for Atrial Fibrillation, Persistent

VOLTage Mapping in Atrial Fibrillation

VOLT-AF
Start date: April 1, 2021
Phase:
Study type: Observational

The purpose of this study is to retrospectively analyze electroanatomical data collected during persistent atrial fibrillation ablation procedures, combined with pre-ablation cardiac CT data, in order to: - define a new method for quantifying left atrial voltage in atrial fibrillation via a total energy map instead of a peak-to-peak amplitude map - confirm the association between epicardial fat localization and atrial conduction slowing

NCT ID: NCT04832607 Recruiting - Clinical trials for Stem Cell Transplant Complications

Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections

TRACE
Start date: August 27, 2019
Phase: Phase 3
Study type: Interventional

Haematopoietic stem cell transplantation (HSCT) can expose patients to a transient but marked immunosuppression, during which viral infections are an important cause of morbidity and mortality. Adoptive transfer of virus-specific T cells is an attractive approach to restore protective T-cell immunity in patients with refractory viral infections after allogeneic HSCT. The aim of this Phase III trial is to confirm efficacy of this treatment in children and adults.